Skip to content

A Multi-Modal Cyclic Peptide Representation Learning Framework for Membrane Permeability Prediction.

Jul 2026 · IEEE journal of biomedical and health informatics · Vol PP · 0 citations
Medicine

TL;DR

MultiMol is a multimodal framework that integrates SMILES sequences, molecular images, molecular graphs, and 3D conformations through tailored pre-training tasks and a scalable fusion mechanism, and consistently outperforms existing methods in cyclic peptide permeability prediction.

Abstract

Cyclic peptide drugs show great potential in antiviral, antibacterial, anticancer, and immunomodulatory therapies, yet accurate prediction of their membrane permeability remains challenging. Existing approaches based on SMILES, molecular graphs, or 3D structures have inherent limitations: SMILES lack spatial information, graphs inadequately capture stereochemistry, and 3D methods are sensitive to conformational variability. Moreover, current multimodal fusion strategies often fail to effectively integrate heterogeneous molecular information. To address these challenges, we propose MultiMol, a multimodal framework that integrates SMILES sequences, molecular images, molecular graphs, and 3D conformations through tailored pre-training tasks and a scalable fusion mechanism. Experiments show that MultiMol consistently outperforms existing methods in cyclic peptide permeability prediction. Visualization and interpretability analyses further demonstrate its strong feature extraction and generalization capabilities. MultiMol also prioritizes promising KRAS-targeting cyclic peptides, supporting its practical utility in virtual screening. The code is available at https://github.com/chaoxiuxiu/multi-mol.

View source

Similar papers

Open access Aug 2026

Multi-solvent conformational ensembles for predicting cyclic peptide permeability

This resource is designed to facilitate the development of deep learning models that incorporate 3D or 4D (trajectory- or ensemble-based) information to improve the prediction of cyclic peptide membrane permeability.

Wei Liu, Pham Hung Nguyen, Chandra S. Verma et al. · 0 citations
Open access Jul 2026

PeptiVerse: A unified platform for therapeutic peptide property prediction

PeptiVerse is a unified platform that leverages large foundation models to predict diverse peptide developability properties from both amino acid sequences and SMILES representations, enabling accessible, scalable analysis for peptide drug design.

Yinuo Zhang, Sophia Tang, Tong Chen et al. · 5 citations · ⚡1
Jul 2026

A Scalable Structure-Aware Multimodal Architecture for Accurate Drug-Target Affinity Prediction.

Accurate prediction of drug-target binding affinity (DTA) is a key task in virtual screening. However, current computational methods face a key challenge: sequence-based approaches often fail to capture critical spatial information, while structure-based models rely on computationally expensive 3D coordinates, which re...

Junlin Xu, Ye Yuan, Menglong Hu et al. · 0 citations
Review Jul 2026

AI-driven discovery of multifunctional peptides: From sequence space to therapeutics.

This review systematically examines the key methodological innovations, including peptide representation learning, multi-modal fusion strategies, multi-label learning paradigms, and emerging predictive frameworks empowered by deep neural architectures and ProtLM-based embeddings, and summarizes the practical applicatio...

Zhiqiang Liang, Yupeng Hao, Junjie Chen · 0 citations
Jul 2026

PSDTA: An Approach to Drug-Target Binding Affinity Prediction by Integrating Physicochemical and Structural Information to Reduce Feature Redundancy.

This work proposes a DTA prediction method, PSDTA, which integrates physicochemical properties into the initial feature representations and explicitly incorporates structural information on amino acids, thereby avoiding the risk of information leakage caused by directly using coordinates as features and enhancing the m...

Shuang Wang, Mao Li, Peifu Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.